UroMems, a global medical technology company developing the first smart automated implant to treat stress urinary ...

BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Boston Scientific acquires Axonics in a $3.7B deal, enhancing its urology portfolio and expanding into sacral neuromodulation ...

Co-founded company that makes sacral neuromodulation device to treat patients with overactive bladder conditions.   IN THE ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

Bladder training is a behavioral treatment that may be effective in eliminating bedwetting (or enuresis) among children. Bladder training seeks to increase the capacity of the bladder and the strength ...

Axonics, Inc. is a medical technology company that develops and commercializes innovative products aimed at treating bladder and bowel dysfunction, primarily operating in the healthcare sector ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a third-quarter loss of $21,000, after reporting a profit in the same period a year ...